← Back to directory

Wan‐Teck Lim

Researcher Next ID · RN-036966

Researcher · Biochemistry, Genetics and Molecular Biology

SingHealth

Singapore, Singapore

Accepting doctoral researchersFunding unknown
Works count
545
Citation count
10,313
H-index
47
i10-index
129

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Lung Cancer Treatments and Mutations
Cancer Immunotherapy and Biomarkers
Cancer Genomics and Diagnostics
Lung Cancer Diagnosis and Treatment
Head and Neck Cancer Studies

Publications

  • Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma

    JAMA · 2023 · https://doi.org/10.1001/jama.2023.20181

  • IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain

    Journal of Thoracic Oncology · 2021 · https://doi.org/10.1016/j.jtho.2021.09.014

  • Genomic landscape of lung adenocarcinoma in East Asians

    Nature Genetics · 2020 · https://doi.org/10.1038/s41588-019-0569-6

  • Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing

    Nature Communications · 2018 · https://doi.org/10.1038/s41467-017-02584-z

  • Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

    Journal of Clinical Oncology · 2018 · https://doi.org/10.1200/jco.2017.77.0388

  • Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study

    Journal of Clinical Oncology · 2017 · 10.1200/jco.2016.67.2048

  • Novel therapeutic targets on the horizon for lung cancer

    The Lancet Oncology · 2016 · 10.1016/s1470-2045(16)30123-1

  • Concurrent Chemo-Radiation With or Without Induction Gemcitabine, Carboplatin, and Paclitaxel: A Randomized, Phase 2/3 Trial in Locally Advanced Nasopharyngeal Carcinoma

    International Journal of Radiation Oncology*Biology*Physics · 2015 · 10.1016/j.ijrobp.2015.01.002

  • An ultra-high-throughput spiral microfluidic biochip for the enrichment of circulating tumor cells

    The Analyst · 2014 · 10.1039/c4an00355a

  • Clinical Validation of an Ultra High-Throughput Spiral Microfluidics for the Detection and Enrichment of Viable Circulating Tumor Cells

    PLoS ONE · 2014 · 10.1371/journal.pone.0099409

  • Isolation and retrieval of circulating tumor cells using centrifugal forces

    Scientific Reports · 2013 · 10.1038/srep01259

  • Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma

    Molecular Therapy · 2013 · 10.1038/mt.2013.242

  • A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer

    Nature Medicine · 2012 · https://doi.org/10.1038/nm.2713

  • A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer

    The Journal of Clinical Endocrinology & Metabolism · 2012 · 10.1210/jc.2012-1520

  • Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients

    Biosensors and Bioelectronics · 2010 · 10.1016/j.bios.2010.07.054

  • Never-Smokers With Lung Cancer: Epidemiologic Evidence of a Distinct Disease Entity

    Journal of Clinical Oncology · 2006 · 10.1200/jco.2005.04.8033

Current projects

    No projects listed.